Predictive Oncology Inc.
POAI
$0.99
-$0.0094-0.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.35M | 1.24M | 948.90K | 1.28M | 1.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.35M | 1.24M | 948.90K | 1.28M | 1.49M |
| Cost of Revenue | 685.60K | 662.90K | 614.10K | 515.10K | 521.90K |
| Gross Profit | 660.80K | 578.00K | 334.80K | 764.80K | 969.30K |
| SG&A Expenses | 10.57M | 11.79M | 12.44M | 13.30M | 14.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.26M | 12.45M | 13.06M | 13.81M | 14.63M |
| Operating Income | -9.91M | -11.21M | -12.11M | -12.53M | -13.14M |
| Income Before Tax | -9.85M | -11.13M | -12.02M | -12.49M | -13.23M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.85 | -11.13 | -12.02 | -12.49 | -13.23 |
| Earnings from Discontinued Operations | -1.04M | -1.53M | -1.95M | -1.55M | -1.55M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.89M | -12.66M | -13.97M | -14.04M | -14.78M |
| EBIT | -9.91M | -11.21M | -12.11M | -12.53M | -13.14M |
| EBITDA | -9.64M | -10.93M | -11.83M | -12.13M | -12.73M |
| EPS Basic | -1.83 | -2.53 | -3.06 | -3.36 | -3.66 |
| Normalized Basic EPS | -1.05 | -1.39 | -1.67 | -1.86 | -2.02 |
| EPS Diluted | -1.83 | -2.53 | -3.06 | -3.36 | -3.66 |
| Normalized Diluted EPS | -1.05 | -1.39 | -1.67 | -1.86 | -2.02 |
| Average Basic Shares Outstanding | 24.89M | 21.80M | 19.19M | 16.82M | 16.15M |
| Average Diluted Shares Outstanding | 24.89M | 21.80M | 19.19M | 16.82M | 16.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |